When making an attempt in investments, people tend to look for role models in a bid to follow in their footsteps. One such people that have always had a great impact on young investors is none other than CEO Jim Tananbaum.
Armed with two and a half decades of health care experience, Dr. Tananbaum decided to start his own company and christened it as Foresite Capital. Foresite Capital deals with seeking upcoming tech companies, scrutinizing them and investing on those that show promise. And since the right doctor has been doing so well in his work, it was no wonder he was named to Forbes’ Midas List 2017 – for the third time in a row reveals inc42.com!
Foresite Capital has been in the business of finding the small tech companies and providing funding for them. As a result of that, these small tech companies with promise can actualize their dream of making an effect in the healthcare world under the keen eye of Dr. Tananbaum himself.
According to pelotontherapeutics.com, before becoming the healthcare mogul that he is today, Dr. Tananbaum began his journey after graduating from Yale University with two degrees, BS BSEE. As if that was not impressive enough, the doctor joined Harvard University and acquired an M.D. and an M.B.A. He then joined the Massachusetts Institute of Technology from where he obtained an M.S. The latter is what makes him one of the most qualified people you will ever hear of in the healthcare world.
Apart from achieving so much in his field as a qualified, sort after medic, Dr. Tananbaum has also proved more than once that he is an impressive entrepreneur – a fact that Forbes has taken notice not once, not twice but thrice, in a row! Dr. Tananbaum was the co-founder of GelTex Pharmaceuticals that was responsible for two, very profitable drugs to the market.
He and his partner later sold the enterprise for an astonishing 1.6 billion dollars. He is also responsible for founding Prospect Venture Partners II and III as well as Theravance, Inc – two very profitable business empires that deal in healthcare provision.